ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.523,17
-0,41%
S&P 500
5.647,81
0,29%
Dow Jones
40.747,35
1,33%
Euro vs US Dollar
1,0881
-0,17%
Bitcoin
64.495,00
-0,55%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AZN
DatumZeitQuelleÜberschriftSymbolFirma
12/03/202201h53Business WireLYNPARZA® (olaparib) approved in the US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancerNASDAQ:AZNAstraZeneca PLC
09/03/202219h17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
07/03/202217h47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
07/03/202205h30GlobeNewswire Inc.HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung CancerNASDAQ:AZNAstraZeneca PLC
01/03/202218h23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
01/03/202218h08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
01/03/202212h56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
01/03/202208h53Dow Jones NewsAstraZeneca, Neurimmune Sign Exclusive Commercialization Global DealNASDAQ:AZNAstraZeneca PLC
23/02/202212h07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
22/02/202223h43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:AZNAstraZeneca PLC
22/02/202223h19Edgar (US Regulatory)Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)NASDAQ:AZNAstraZeneca PLC
22/02/202214h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
22/02/202213h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
22/02/202212h45Dow Jones NewsAstraZeneca's Nonexecutive Chairman Leif Johansson to Retire in 2023NASDAQ:AZNAstraZeneca PLC
22/02/202209h01Dow Jones NewsAstraZeneca, Honeywell International to Develop More Environmentally-Friendly InhalersNASDAQ:AZNAstraZeneca PLC
22/02/202208h01PR Newswire (US)HONEYWELL TEAMS WITH ASTRAZENECA TO DEVELOP NEXT-GENERATION RESPIRATORY INHALERS THAT USE NEAR-ZERO GLOBAL WARMING POTENTIAL PROPELLANTNASDAQ:AZNAstraZeneca PLC
21/02/202210h38Dow Jones NewsAstraZeneca, Daiichi Sankyo Report Positive Trial Results for Enhertu Breast-Cancer Treatment -- UpdateNASDAQ:AZNAstraZeneca PLC
21/02/202208h52Dow Jones NewsAstraZeneca Reports 'Historic' Trial Results for Enhertu Cancer TreatmentNASDAQ:AZNAstraZeneca PLC
16/02/202212h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
16/02/202208h52Dow Jones NewsAstraZeneca's Saphnelo Approved in EU for Treatment of Systemic Lupus ErythematosusNASDAQ:AZNAstraZeneca PLC
15/02/202208h39Dow Jones NewsAstraZeneca Says Lynparza Combination Delays Progression Risk in Prostate CancerNASDAQ:AZNAstraZeneca PLC
11/02/202217h45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
10/02/202223h55Dow Jones NewsAstraZeneca Says Its ADRs Will Join NASDAQ-100 Index Feb. 22NASDAQ:AZNAstraZeneca PLC
10/02/202223h00GlobeNewswire Inc.AstraZeneca PLC – ADR to Join the NASDAQ-100 Index Beginning February 22, 2022NASDAQ:AZNAstraZeneca PLC
10/02/202212h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
10/02/202210h36Dow Jones NewsAstraZeneca Swung to 4Q Loss Despite Revenue Rise; Expects $2.1 Billion Restructuring Charge -- UpdateNASDAQ:AZNAstraZeneca PLC
10/02/202209h29Dow Jones NewsAstraZeneca Swung to 4Q Loss Despite Revenue Rise; Expects $2.1 Billion Restructuring ChargeNASDAQ:AZNAstraZeneca PLC
07/02/202222h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AZNAstraZeneca PLC
04/02/202215h08Edgar (US Regulatory)Schedule 13gNASDAQ:AZNAstraZeneca PLC
01/02/202216h57Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
 Showing the most relevant articles for your search:NASDAQ:AZN

Kürzlich von Ihnen besucht

NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
DBI
TDXP
Tec DAX
CCOM
US500
US 500
TG
RHM
Rheinmetall
TG
BAYN
Bayer
TG
LHA
Deutsche Lufthansa
USOTC
BNPQY
BNP Paribas (QX)
TG
432
Arbor Metals
TG
DBK
Deutsche Bank
TG
MBG
MercedesBenz
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten